GenFlat Holdings, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that GenFlat Holdings, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $7.9K | Sep 19, 2025 |
| FY2025 | Jun 30, 2024 | $5.2K | Sep 19, 2025 |
| FY2024 | Jun 30, 2023 | $0 | Oct 1, 2024 |
| FY2023 | Feb 28, 2023 | $1.9K | May 30, 2023 |
| FY2023 | Feb 28, 2022 | $28.9K | May 30, 2023 |
| FY2022 | Feb 28, 2021 | $4.0K | Jul 15, 2022 |
| FY2021 | Feb 29, 2020 | $0 | Jun 7, 2021 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($169.4K) | Sep 19, 2025 |
| FY2025 | Jun 30, 2024 | ($163.3K) | Sep 19, 2025 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($4.67M) | Sep 19, 2025 |
| FY2025 | Jun 30, 2024 | ($1.21M) | Sep 19, 2025 |
| FY2024 | Jun 30, 2023 | ($875.8K) | Oct 1, 2024 |
| FY2023 | Feb 28, 2023 | ($166.6K) | May 30, 2023 |
| FY2023 | Feb 28, 2022 | ($1.65M) | May 30, 2023 |
| FY2022 | Feb 28, 2021 | $1.63M | Jul 15, 2022 |
| FY2021 | Feb 29, 2020 | ($19.9K) | Jun 7, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($4.71M) | Sep 19, 2025 |
| FY2025 | Jun 30, 2024 | ($1.23M) | Sep 19, 2025 |
| FY2024 | Jun 30, 2023 | ($873.8K) | Oct 1, 2024 |
| FY2023 | Feb 28, 2023 | ($170.4K) | May 30, 2023 |
| FY2023 | Feb 28, 2022 | ($1.63M) | May 30, 2023 |
| FY2022 | Feb 28, 2021 | ($1.63M) | Jul 15, 2022 |
| FY2021 | Feb 29, 2020 | ($19.9K) | Jun 7, 2021 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $103.3K | Sep 19, 2025 |
| FY2025 | Jun 30, 2024 | $0 | Sep 19, 2025 |
| FY2024 | Jun 30, 2023 | $395.7K | Oct 1, 2024 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($1.18M) | Sep 19, 2025 |
| FY2025 | Jun 30, 2024 | ($2.44M) | Sep 19, 2025 |
| FY2024 | Jun 30, 2023 | ($1.29M) | Oct 1, 2024 |
| FY2023 | Feb 28, 2023 | ($51.5K) | May 30, 2023 |
| FY2023 | Feb 28, 2022 | ($280.7K) | May 30, 2023 |
| FY2022 | Feb 28, 2021 | ($137.8K) | Jul 15, 2022 |
| FY2021 | Feb 29, 2020 | ($18.9K) | Jun 7, 2021 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $0 | Sep 19, 2025 |
| FY2025 | Jun 30, 2024 | $0 | Sep 19, 2025 |
| FY2024 | Jun 30, 2023 | $2.4K | Oct 1, 2024 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $686.1K | Sep 19, 2025 |
| FY2025 | Jun 30, 2024 | $1.80M | Sep 19, 2025 |
| FY2024 | Jun 30, 2023 | $879.7K | Oct 1, 2024 |
| FY2023 | Feb 28, 2023 | $121.1K | May 30, 2023 |
| FY2023 | Feb 28, 2022 | $165.6K | May 30, 2023 |
| FY2022 | Feb 28, 2021 | $35.1K | Jul 15, 2022 |
| FY2021 | Feb 29, 2020 | $172.8K | Jun 7, 2021 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $394.0K | Sep 19, 2025 |
| FY2025 | Jun 30, 2024 | $277.3K | Sep 19, 2025 |
| FY2024 | Jun 30, 2023 | $172.1K | Oct 1, 2024 |
| FY2023 | Feb 28, 2023 | $179.8K | May 30, 2023 |
| FY2023 | Feb 28, 2022 | $336.9K | May 30, 2023 |
| FY2022 | Feb 28, 2021 | $71.7K | Jul 15, 2022 |
| FY2021 | Feb 29, 2020 | $0 | Jun 7, 2021 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $295.5K | Sep 19, 2025 |
| FY2025 | Jun 30, 2024 | $1.48M | Sep 19, 2025 |
| FY2024 | Jun 30, 2023 | $707.6K | Oct 1, 2024 |
| FY2023 | Feb 28, 2023 | ($58.7K) | May 30, 2023 |
| FY2023 | Feb 28, 2022 | ($171.4K) | May 30, 2023 |
| FY2023 | Feb 28, 2021 | ($36.6K) | May 30, 2023 |
| FY2022 | Feb 29, 2020 | $172.8K | Jul 15, 2022 |
| FY2021 | Sep 8, 2019 | $0 | Jun 7, 2021 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($7.82M) | Sep 19, 2025 |
| FY2025 | Jun 30, 2024 | ($3.15M) | Sep 19, 2025 |
| FY2024 | Jun 30, 2023 | ($1.94M) | Oct 1, 2024 |
| FY2023 | Feb 28, 2023 | ($3.47M) | May 30, 2023 |
| FY2023 | Feb 28, 2022 | ($3.30M) | May 30, 2023 |
| FY2022 | Feb 28, 2021 | ($1.65M) | Jul 15, 2022 |
| FY2021 | Feb 29, 2020 | ($19.9K) | Jun 7, 2021 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 0 | Sep 19, 2025 |
| FY2025 | Jun 30, 2024 | 0 | Sep 19, 2025 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 0 | Sep 19, 2025 |
| FY2025 | Jun 30, 2024 | 0 | Sep 19, 2025 |
| FY2023 | Feb 28, 2023 | 0 | May 30, 2023 |
| FY2023 | Feb 28, 2022 | 0 | May 30, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 10.72M | Sep 19, 2025 |
| FY2025 | Jun 30, 2024 | 10.55M | Sep 19, 2025 |
| FY2025 | Dec 20, 2023 | 10.54M | Sep 19, 2025 |
| FY2025 | Oct 18, 2023 | 10.44M | Sep 19, 2025 |
| FY2024 | Jun 30, 2023 | 10.21M | Oct 1, 2024 |
| FY2023 | Feb 28, 2023 | 21.30M | May 30, 2023 |
| FY2023 | Feb 28, 2022 | 20.85M | May 30, 2023 |
| FY2022 | Feb 28, 2021 | 19.59M | Jul 15, 2022 |
| FY2021 | Feb 29, 2020 | 19.59M | Jun 7, 2021 |